Authors: DHAESE PC COUTTENYE MM GOODMAN WG LEMONIATOU E DIGENIS P SOTORNIK I FAGALDE A BARSOUM RS LAMBERTS LV DEBROE ME

Citation: Pc. Dhaese et al., USE OF THE LOW-DOSE DESFERRIOXAMINE TEST TO DIAGNOSE AND DIFFERENTIATE BETWEEN PATIENTS WITH ALUMINUM-RELATED BONE-DISEASE, INCREASED RISK FOR ALUMINUM TOXICITY, OR ALUMINUM OVERLOAD, Nephrology, dialysis, transplantation, 10(10), 1995, pp. 1874-1884

Authors: DHAESE PC COUTTENYE MM LAMBERTS LV GOODMAN WG NUYTS GD LEMONIATOU E DIGENIS P SOTORNIK I FAGALDE A DEBROE ME

Citation: Pc. Dhaese et al., VALUE OF THE LOW-DOSE DESFERRIOXAMINE (DFO) TEST IN THE DIAGNOSIS OF ALUMINUM-RELATED BONE-DISEASE (ARBD) IN DIALYSIS (D) PATIENTS, Kidney international, 46(5), 1994, pp. 1461-1461

Authors: DHAESE PC LAMBERTS LV VERPOOTEN GA VANEERDEWEG W JURGENS A ARAKELIAN S BABLOYAN A DIGENIS P TJALMA W DEBROE ME

Citation: Pc. Dhaese et al., URINARY AND BILIARY-EXCRETION OF ALUMINOXAMINE AND FERRIOXAMINE IN DOGS WITH VARIOUS RENAL-FUNCTION, Kidney international, 45(1), 1994, pp. 76-84